This week on Surfing the NASH Tsunami, we are offering a co-host ‘roundtable’ catch-up between Jörn Schattenberg, Louise Campbell and Roger Green. This is a fun, casual conversation that looks into first quarter highlights and a preview of what’s to come in quarter two of 2023.
Jörn recounts a productive trip to California where he attended the 3rd Annual Liver Connect Conference organized by Chronic Liver Disease Foundation. He shares his highlights from the meeting including a summary of a powerful presentation by Scott Friedman on ‘hot’ versus ‘cold’ fibrosis, cirrhosis, combination therapies and more.
Louise speaks to the intensity involved in reviewing publication for FibroScan approval in primary care pathways in the UK. One benefit of the lengthy protocols that NICE considers is that this ultimately enables for world-leading cost-benefit analysis. The group goes on to discuss how different systems contribute to the field through their different strengths.
Roger uncovers a new metaphor for describing fatty liver disease and announces exciting plans for the podcast’s 4th anniversary special.
Among a number of other insights emerging from this session, the Surfers also discuss what is happening in the space of drug development and impending approvals, the strength in allied health professionals and primary care pathways for fighting fatty liver.
If you enjoy the episode, have questions or interest around its contents and Fatty Liver disease, we kindly ask that you submit reviews wherever you download our discussions. Alternatively, you can write to us directly at questions@SurfingNASH.com.
Stay Safe and Surf On!
